je.st
news
Tag: transplant
With the most-edited genomes of all time, Harvards pigs could spark a transplant revolution
2015-10-09 15:38:55| Extremetech
By smashing the prior gene-editing record in pig embryos, scientists have taken a big step toward a much-needed revolution in medicine.
Tags: time
revolution
spark
pigs
QIAGEN Introduces QuantiFERON Monitor for Tracking Immune Function in Solid Organ Transplant Patients and for Research Into other Applications
2015-02-02 11:32:10| Industrial Newsroom - All News for Today
HILDEN, Germany, and GERMANTOWN, Maryland, - QuantiFERON Monitor (QFM) launches in Europe for monitoring immune function - Target markets include transplant patients and research in managing immune modulation and suppression - Novel diagnostic with significant potential to expand clinical utility and to address...
Tags: other
into
research
function
Foreign transplant at home in Buffalo investment community
2015-01-22 23:34:39| Steel - Topix.net
Neil Arnold ended up in Buffalo after his company moved here from Toronto in 1991 - and he stayed through a career that saw him rise to high levels of corporate finance. Neil Arnold ended up in Buffalo after his company moved here from Toronto in 1991 - and he stayed through a career that saw him rise to high levels of corporate finance.
Tags: home
community
foreign
investment
Paralyzed man walks again after surgeons transplant cells from his nose to his spine
2014-10-22 19:41:05| Extremetech
A paralyzed man just had cells from inside his nose transplanted into his spine. Now the man walks, albeit still using a frame. To dissect exactly how this procedure appears to have worked we need to understand precisely what was done during his incredible surgery, and what it is about these peculiar cells that enables neurons to reconnect.
Merck Initiates Phase 3 Study of Letermovir, an Investigational Antiviral for Prevention of Cytomegalovirus (CMV) Infection in High-Risk Bone Marrow Transplant Patients
2014-07-24 14:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir (MK-8228), an investigational antiviral agent. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orRobert Consalvo, 908-423-6595orInvestor:Joseph Romanelli, 908-423-5185orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: study
phase
patients
prevention